Association of a Third Dose of BNT162b2 Vaccine With Incidence of SARS-CoV-2 Infection Among Health Care Workers in Israel | Global Health | JAMA

This cohort study estimates the association of a BNT162b2 (Pfizer-BioNTech) vaccine booster dose with SARS-CoV-2 infections among health care workers in Israel

Related Keywords

Helsinki ,Eteläuomen Läi ,Finland ,Alona ,H Efa ,Israel ,Tel Aviv ,Israeli ,Michele Plesser ,Shabi Shamlo ,Ettie Oziel ,Oryan Henig ,Avi Ben Zaken ,Tzvi Gregory Avishai ,Tanya Grossman ,Tel Aviv Sourasky Medical Center ,Ministry Of Health ,Israeli Council For Higher Education ,Department Of Infectious Diseases ,Association Between Booster Dose Administration ,Pfizer ,Aviv Sourasky Medical Center ,Association Between Anti ,Siemens ,Israeli Ministry Of Health ,Meijer ,Weizmann Data Science Research Center ,Israeli Ministry ,Dependent Cox Regression Analysis ,Density Over Time ,Baseline Anti ,Between Booster Dose Administration ,Between Anti ,Breakthrough Infections ,Participants Vaccinated With ,Infectious Diseases ,Infection Control ,Drs Spitzer ,Interest Disclosures ,Tel Aviv Sourasky Medical ,Israeli Council ,Higher Education ,Lital Zand ,Lihi Turgeman ,Eti Amzel ,Alona Green ,